Sg Americas Securities, LLC Fate Therapeutics Inc Transaction History

Sg Americas Securities, LLC

  • $24.4 Billion
  • Q4 2024

A detailed history of Sg Americas Securities, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 44,874 shares of FATE stock, worth $59,233. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,874
Previous 34,363 30.59%
Holding current value
$59,233
Previous $120,000 38.33%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025
BUY
$1.61 - $3.35 $16,922 - $35,211
10,511 Added 30.59%
44,874 $74,000
Q3 2024

Oct 03, 2024
SELL
$3.12 - $5.57 $6,268 - $11,190
-2,009 Reduced 5.52%
34,363 $120,000
Q2 2024

Jul 12, 2024
SELL
$3.26 - $7.08 $3,533 - $7,674
-1,084 Reduced 2.89%
36,372 $119,000
Q1 2024

May 06, 2024
SELL
$3.54 - $8.35 $187,963 - $443,359
-53,097 Reduced 58.64%
37,456 $275,000
Q4 2023

Jan 12, 2024
BUY
$1.65 - $3.94 $27,903 - $66,629
16,911 Added 22.96%
90,553 $339,000
Q3 2023

Oct 13, 2023
BUY
$2.02 - $5.04 $148,756 - $371,155
73,642 New
73,642 $156,000
Q1 2023

Apr 28, 2023
BUY
$4.24 - $11.12 $46,640 - $122,319
11,000 New
11,000 $63,000
Q2 2022

Jul 29, 2022
SELL
$17.78 - $42.39 $1.63 Million - $3.88 Million
-91,629 Reduced 87.51%
13,076 $324,000
Q1 2022

Apr 29, 2022
SELL
$29.67 - $60.28 $9.36 Million - $19 Million
-315,485 Reduced 75.08%
104,705 $4.06 Million
Q4 2021

Feb 07, 2022
BUY
$47.84 - $64.34 $17.4 Million - $23.4 Million
363,576 Added 642.2%
420,190 $24.6 Million
Q3 2021

Nov 01, 2021
BUY
$59.27 - $95.73 $209,993 - $339,171
3,543 Added 6.68%
56,614 $3.36 Million
Q2 2021

Aug 12, 2021
BUY
$67.25 - $92.52 $2.38 Million - $3.27 Million
35,372 Added 199.85%
53,071 $4.61 Million
Q1 2021

May 13, 2021
BUY
$72.16 - $117.4 $1.07 Million - $1.74 Million
14,820 Added 514.76%
17,699 $1.46 Million
Q4 2020

Feb 04, 2021
SELL
$38.09 - $100.95 $2.83 Million - $7.51 Million
-74,392 Reduced 96.27%
2,879 $262,000
Q3 2020

Nov 09, 2020
BUY
$30.41 - $40.5 $2.22 Million - $2.95 Million
72,860 Added 1651.78%
77,271 $3.09 Million
Q2 2020

Jul 20, 2020
SELL
$20.21 - $35.23 $424,895 - $740,675
-21,024 Reduced 82.66%
4,411 $151,000
Q1 2020

Apr 30, 2020
BUY
$17.28 - $31.88 $439,516 - $810,867
25,435 New
25,435 $565,000
Q2 2019

Jul 29, 2019
SELL
$15.61 - $20.44 $150,433 - $196,980
-9,637 Closed
0 $0
Q1 2019

Apr 29, 2019
BUY
$13.15 - $18.71 $126,726 - $180,308
9,637 New
9,637 $169,000
Q4 2017

Jan 24, 2018
SELL
$3.94 - $6.64 $41,748 - $70,357
-10,596 Closed
0 $0
Q3 2017

Nov 07, 2017
BUY
$2.6 - $4.31 $27,549 - $45,668
10,596
10,596 $42,000

Others Institutions Holding FATE

# of Institutions
176
Shares Held
113M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $128M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email